All articles

Daily brief

CAR-T insurance listings: payment is not guaranteed

The November 15 briefing reports two insurance listings in China and a proposed research center in Cairo.

By Medical2China · Video date

Three things to know

  1. The video reports that JW Therapeutics’ relma-cel entered China’s basic medical insurance list. CARsgen’s satri-cel entered a separate commercial-insurance innovative drug list for selected patients with previously treated advanced gastric or gastroesophageal junction cancer.

  2. Both listings are described as taking effect on January 1, 2027. A listing does not guarantee insurer payment or equivalent coverage for overseas patients.

  3. Egyptian officials discussed Chinese medicine training and research. The Egyptian Chinese University outlined a specialized research center, but its budget and opening date remain unconfirmed.

This is a dated video briefing. Reports and availability may have changed since it was recorded; confirm current details before making plans.